Literature DB >> 11293495

Classical malignant rhabdoid tumor of central nervous system in 9-year-old Korean.

H K Chang1, J H Kim.   

Abstract

A Malignant rhabdoid tumor (MRT) arising in the right temporoparietal lobe of a 9-year-old boy is described along with the results of an immunohistochemical study. The patient initially sought medical attention for a ptosis and right sided headache. The child underwent a subtotal resection of the tumor, followed by radiotherapy and systemic chemotherapy, but died three years after surgery. A MRT, a primary neoplasm of the central nervous system (CNS), is an entity of unknown histogenesis with a dismal prognosis, which only occurs in early childhood. Histologically similar tumors with more varied morphological features have been designated as an atypical teratoid/rhabdoid tumor. However, a classical MRT is extremely rare in the CNS and our case represents a classical CNS MRT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11293495     DOI: 10.3349/ymj.2001.42.1.142

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  4 in total

1.  How specific is the MRI appearance of supratentorial atypical teratoid rhabdoid tumors?

Authors:  Kong Jung Au Yong; Jacob L Jaremko; Lennart Jans; Ravi Bhargava; Lee T Coleman; Vivek Mehta; Michael R Ditchfield
Journal:  Pediatr Radiol       Date:  2012-11-10

Review 2.  Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy.

Authors:  Sarah E Squire; Michael D Chan; Karen J Marcus
Journal:  J Neurooncol       Date:  2006-07-20       Impact factor: 4.130

3.  Primary malignant rhabdoid tumor of the central nervous system--a comprehensive review.

Authors:  Ismail H Tekkök; Aydin Sav
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

4.  Imaging findings of CNS atypical teratoid/rhabdoid tumors.

Authors:  Atilla Arslanoglu; Nafi Aygun; Deapak Tekhtani; Leslie Aronson; Ken Cohen; Peter C Burger; David M Yousem
Journal:  AJNR Am J Neuroradiol       Date:  2004-03       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.